File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor

TitleElevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor
Authors
Issue Date2022
Citation
Oncogene, 2022, v. 41, p. 732-744 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/313592
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSUN, L-
dc.contributor.authorXi, S-
dc.contributor.authorZhou, Z-
dc.contributor.authorZhang, F-
dc.contributor.authorHu, P-
dc.contributor.authorCUI, Y-
dc.contributor.authorWu, S-
dc.contributor.authorWang, Y-
dc.contributor.authorWU, S-
dc.contributor.authorWang, Y-
dc.contributor.authorDu, Y-
dc.contributor.authorZheng, J-
dc.contributor.authorYang, H-
dc.contributor.authorCHEN, M-
dc.contributor.authorYAN, Q-
dc.contributor.authorYU, D-
dc.contributor.authorSHI, C-
dc.contributor.authorZHANG, Y-
dc.contributor.authorXie, D-
dc.contributor.authorGuan, X-
dc.contributor.authorLi, Y-
dc.date.accessioned2022-06-17T06:48:41Z-
dc.date.available2022-06-17T06:48:41Z-
dc.date.issued2022-
dc.identifier.citationOncogene, 2022, v. 41, p. 732-744-
dc.identifier.urihttp://hdl.handle.net/10722/313592-
dc.languageeng-
dc.relation.ispartofOncogene-
dc.titleElevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor-
dc.typeArticle-
dc.identifier.emailGuan, X: xyguan@hku.hk-
dc.identifier.authorityGuan, X=rp00454-
dc.identifier.doi10.1038/s41388-021-02130-8-
dc.identifier.hkuros333602-
dc.identifier.volume41-
dc.identifier.spage732-
dc.identifier.epage744-
dc.identifier.isiWOS:000723571700001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats